CEL-SCI Corporation (AMEX: CVM), a biotechnology company focused on immunotherapy products for cancer and infectious diseases, similar to companies like ImmunoGen Inc. (NASDAQ: IMGN) and Immunomedics Inc. (NASDAQ: IMMU), represents a misunderstood and highly promising play on head and neck cancer and other diseases. The company’s lead investigational therapy, Multikine® is an immunotherapeutic agent that